Abstract
Chemiluminescence has traditionally been used to study the nature of the oxidative bactericidal mechanisms of neutrophils and monocytes, intrinsic defects of abnormally functioning neutrophils or monocytes and cell activation. During the last ten years, Chemiluminescence has been applied in a wide variety of techniques, including immunoassays, protein blotting and toxicological and pharmacological tests (e.g. after exposure to antibiotic or immunomodulators agents, such as adjuvants and cytotoxic drugs). In this review, we discuss some promising clinical applications of Chemiluminescence in clinical immunology for the study of autoimmune diseases, inflammatory responses, endocrine disorders, immunodeficient states, mucosal immune responses against drugs and pathogens and host responses against tumors and infections. Further, we review the numerous advantages of Chemiluminescence-based methods over other methods to assay the same endpoints, which facilitate their use in the current practice of clinical immunology.
Keywords: Chemiluminescence assays, phagocytic activity, clinical immunology, tumors, immunodeficiency's states, inflammatory response, infectious diseases, endocrine disorders, cell activation, adjuvants, cytotoxic drugs, autoimmune diseases, inflammatory responses, immunodeficiencys states, electromagnetic radiation, neutrophils, PMN, monocytes, MN, NADPH oxidase, Luminol, singlet oxygen, superoxide anion, hydrogen peroxide, hypochlorous acid, IL-1 receptor antagonist, Nitric Oxide (NO)/peroxynitrite formation, polymorphonuclear leukocytes, rheumatism, PCR/RT-PCR techniques, metabolic ketosis, Neuramidinase inhibitors, Treponema pallidum, A. phagocytophilum, Chlamydia pneumoniae, growth hormone, prolactine, Vitamin E
Mini-Reviews in Medicinal Chemistry
Title: Recent Applications of Chemiluminescence Assays in Clinical Immunology
Volume: 10 Issue: 14
Author(s): A. R. Rodriguez-Orozco, H. Ruiz-Reyes and N. Medina-Serriteno
Affiliation:
Keywords: Chemiluminescence assays, phagocytic activity, clinical immunology, tumors, immunodeficiency's states, inflammatory response, infectious diseases, endocrine disorders, cell activation, adjuvants, cytotoxic drugs, autoimmune diseases, inflammatory responses, immunodeficiencys states, electromagnetic radiation, neutrophils, PMN, monocytes, MN, NADPH oxidase, Luminol, singlet oxygen, superoxide anion, hydrogen peroxide, hypochlorous acid, IL-1 receptor antagonist, Nitric Oxide (NO)/peroxynitrite formation, polymorphonuclear leukocytes, rheumatism, PCR/RT-PCR techniques, metabolic ketosis, Neuramidinase inhibitors, Treponema pallidum, A. phagocytophilum, Chlamydia pneumoniae, growth hormone, prolactine, Vitamin E
Abstract: Chemiluminescence has traditionally been used to study the nature of the oxidative bactericidal mechanisms of neutrophils and monocytes, intrinsic defects of abnormally functioning neutrophils or monocytes and cell activation. During the last ten years, Chemiluminescence has been applied in a wide variety of techniques, including immunoassays, protein blotting and toxicological and pharmacological tests (e.g. after exposure to antibiotic or immunomodulators agents, such as adjuvants and cytotoxic drugs). In this review, we discuss some promising clinical applications of Chemiluminescence in clinical immunology for the study of autoimmune diseases, inflammatory responses, endocrine disorders, immunodeficient states, mucosal immune responses against drugs and pathogens and host responses against tumors and infections. Further, we review the numerous advantages of Chemiluminescence-based methods over other methods to assay the same endpoints, which facilitate their use in the current practice of clinical immunology.
Export Options
About this article
Cite this article as:
R. Rodriguez-Orozco A., Ruiz-Reyes H. and Medina-Serriteno N., Recent Applications of Chemiluminescence Assays in Clinical Immunology, Mini-Reviews in Medicinal Chemistry 2010; 10 (14) . https://dx.doi.org/10.2174/138955710793564142
DOI https://dx.doi.org/10.2174/138955710793564142 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Genomic Strategies in Pharmacology of Asthma and Autoimmunity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer
Current Medicinal Chemistry Regulation of B-Cell Activation by Complement Receptors CD21 and CD35
Current Pharmaceutical Design The Medical Functions of Probiotics and Their Role in Clinical Nutrition
Current Nutrition & Food Science Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy
Current Rheumatology Reviews Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
Current Cardiology Reviews Phosphoinositide 3-Kinase Gamma (PI3Kγ) Inhibitors for the Treatment of Inflammation and Autoimmune Disease
Recent Patents on Inflammation & Allergy Drug Discovery Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Current Neuropharmacology From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
Current Drug Targets - CNS & Neurological Disorders Chemokines and Autoimmune Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Autoimmune (Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA) – Animal Models as a Proof of Concept
Current Medicinal Chemistry Genetic and Pharmacological Modulation of Dendritic Cell-T Cell Interactions as a Therapeutic Strategy for Systemic Lupus Erythematosus
Current Gene Therapy Neuropeptide - Adipose Tissue Communication and Intestinal Pathophysiology
Current Pharmaceutical Design Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy
Letters in Drug Design & Discovery Role of Inhibitory BCR Co-Receptors in Immunity
Infectious Disorders - Drug Targets Role of Regulatory T Cells in Allergy: Implications for Therapeutic Strategy
Inflammation & Allergy - Drug Targets (Discontinued) B-Cell Based Gene Therapy for Autoimmune Diseases
Infectious Disorders - Drug Targets